547 related articles for article (PubMed ID: 31729980)
1. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
2. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
3. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.
Zhu X; Yan H; Xia M; Chang X; Xu X; Wang L; Sun X; Lu Y; Bian H; Li X; Gao X
Lipids Health Dis; 2018 May; 17(1):114. PubMed ID: 29759071
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
6. Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation.
Lee JH; Lee GY; Jang H; Choe SS; Koo SH; Kim JB
Hepatology; 2014 Sep; 60(3):844-57. PubMed ID: 24425205
[TBL] [Abstract][Full Text] [Related]
7. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
10. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
[TBL] [Abstract][Full Text] [Related]
11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
12. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.
Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ
Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393
[TBL] [Abstract][Full Text] [Related]
13. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
[TBL] [Abstract][Full Text] [Related]
14. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
15. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.
Chen A; Chen X; Cheng S; Shu L; Yan M; Yao L; Wang B; Huang S; Zhou L; Yang Z; Liu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):538-548. PubMed ID: 29486327
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
Wu H; Ng R; Chen X; Steer CJ; Song G
Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
[TBL] [Abstract][Full Text] [Related]
17. HCBP6 upregulates human SREBP1c expression by binding to C/EBPβ-binding site in the SREBP1c promoter.
Yang X; Han M; Liu S; Yuan X; Liu X; Feng S; Zhou L; Li Y; Lu H; Cheng J; Lin S
BMB Rep; 2018 Jan; 51(1):33-38. PubMed ID: 29187281
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of gomisin N against hepatic steatosis through AMPK activation.
Yun YR; Kim JH; Kim JH; Jung MH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812
[TBL] [Abstract][Full Text] [Related]
19. SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c.
Jiao Y; Zhao J; Zhang Z; Li M; Yu X; Yang Y; Liu J; Liao S; Li D; Wang Y; Zhang D; Chen Y; Shi G; Liu B; Lu Y; Li X
Diabetes; 2018 Nov; 67(11):2227-2238. PubMed ID: 30181160
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatic liver X receptor α- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of non-alcoholic steatohepatitis in rats.
Ai ZL; Zhu CH; Min M; Wang J; Lan CH; Fan LL; Sun WJ; Chen DF
J Int Med Res; 2011; 39(4):1219-29. PubMed ID: 21986124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
